San Diego based Replicate Bioscience believes that self-replicating RNA (srRNA) has key advantages over linear or circular RNA. Last year Novo signed on as a partner in obesity and diabetes
- 1 day ago
- 1 min read
Co-Founder and CEO Nathaniel Wang describes the biology, which is designed to be more durable, tolerable, and offer less frequent dosing. The lead internal program is a rabies vaccine, and there is early work on mono, RSV/hMPV/PIV, gout, and a cancer vaccine platform.
Coverage brought to you by











.png)